Advertisement
Australia markets open in 4 hours 51 minutes
  • ALL ORDS

    8,065.50
    +113.20 (+1.42%)
     
  • AUD/USD

    0.6597
    -0.0029 (-0.44%)
     
  • ASX 200

    7,793.30
    +110.90 (+1.44%)
     
  • OIL

    78.51
    +0.03 (+0.04%)
     
  • GOLD

    2,322.80
    -8.40 (-0.36%)
     
  • Bitcoin AUD

    95,843.78
    -202.10 (-0.21%)
     
  • CMC Crypto 200

    1,308.09
    -57.04 (-4.18%)
     

Valeant’s Quarterly Revenue Trend and Estimates

Valeant’s Quarterly Revenue Trend and Estimates

Valeant Pharmaceutical’s (VRX) revenues decreased ~5.4% to ~$2.0 billion during the first quarter—compared to revenues of ~$2.1 billion during the first quarter of 2017. Valeant met Wall Street analysts’ revenue estimates and reported revenues of ~$1.995 billion—compared to estimates of ~$1.944 billion during the first quarter. Valeant reported organic growth of 2% in total revenues during the first quarter.